Buscar

01/01/2022 Reduced Dose Intravesical Bacillus Calmette-Guerin: Why It Might Not Matter
Kamat, AM, Lobo, N, Lerner, SP, Li, R, Matulay, JT, Palou, J, Witjes, JA, Roupret, M, Smith, AB, Chang, SS, Shore, ND, Steinberg, GD, Dinney, CP, Svatek, RS, Lamm, DL. Reduced Dose Intravesical Bacillus Calmette-Guerin: Why It Might Not Matter. Bladder Cancer. 2022; 8(2)DOI:10.3233/BLC-211648. PMID:. IF:1.100(Q4/9D).
01/01/2022 Predicting Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer: Systematic Review on the Performance of Risk Stratification Models
Guerrero-Ramos, F, Subiela, JD, Rodriguez-Faba, O, Aumatell, J, Manfredi, C, Bozzini, G, Romero-Otero, J, Counago, F. Predicting Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer: Systematic Review on the Performance of Risk Stratification Models. Bladder Cancer. 2022; 8(4)DOI:10.3233/BLC-220055. PMID:. IF:1.100(Q4/9D).
01/01/2022 A Multicenter Study of 2-year Outcomes Following Hyperthermia Therapy with Mitomycin C in Treating Non-Muscle Invasive Bladder Cancer: HIVEC-E
Tan, WP, Bello, AP, Alvarez, CG, Guerrero-Ramos, F, Gonzalez-Padilla, DA, Nzeh, C, De la Morena, JM, De Torres, IGV, Hendricksen, K, Goizueta, FJD, Del Alamo, JF, Chiancone, F, Fedelini, P, Poggio, M, Porpiglia, F, Rodriguez, VCG, Torres, JM, Wilby, D, Robinson, R, Sousa-Escandon, A, Mata, JL, Moreno, JLP, Molina, FD, Semino, MAA, Stemberger, AT, Escudero, JC, Redorta, JP, Tan, WS. A Multicenter Study of 2-year Outcomes Following Hyperthermia Therapy with Mitomycin C in Treating Non-Muscle Invasive Bladder Cancer: HIVEC-E. Bladder Cancer. 2022; 8(4)DOI:10.3233/BLC-220026. PMID:. IF:1.100(Q4/9D).
01/01/2022 Does ureteral access sheath have an impact on ureteral injury
Asutay, MK, Lattarulo, M, Liourdi, D, Al-Aown, AM, Pagonis, K, Nedal, N, Pietropaolo, A, Emiliani, E, Liatsikos, E, Kallidonis, P. Does ureteral access sheath have an impact on ureteral injury. Urology Annals. 2022; 14(1)DOI:10.4103/UA.UA_163_20. PMID:35197695. IF:(Q/D).